Tender detail

Heparin sodium II

Summary

The Institute for Clinical and Experimental Medicine is procuring injectable medicinal products containing heparin sodium (ATC B01AB01) to treat patients for the approved indications in the Summary of Product Characteristics in force on the bid submission date. The procurement comprises one lot, with an estimated value of CZK 41,786,000 and a planned duration of 48 months. Delivery is for the Institute in Prague.

Reference number
786056-2026
Buyer
Institut klinické a experimentální medicíny
Country
Czechia (CZE)
Procedure
Open procedure
CPV
33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system
Deadline
2026-12-16
Status
Open
Contract subject
Supplies
Estimated value
41 786 000,00 CZK
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.